- About us
- Value, Pricing & Access
- Medical & Scientific Affairs
- Centers of Excellence
- Join Putnam
Demonstrate value through proven analytical methods and lead the discussion for valuing new innovations.
Our team of health economists and HEOR strategists apply deep HTA experience to inform your reimbursement strategy, guide you through HTA processes, and support your value communications strategies beyond product launch.
Leverage proven analytical methods for HEOR evidence generation with our commercial experience and scientific expertise. Our economic modelling and HTA specialists can inform pricing strategy, identify priorities for evidence generation, and develop global models that meet the latest HTA requirements, including for local submissions.
Beyond that, we maintain a team of highly qualified Patient Reported Outcomes (PRO) specialists who generate and analyze health-related utility data to strengthen your product’s value proposition.
Our HEOR strategies include:
Get the latest insights and perspectives from our experts.
Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment...
Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th.
A company was approaching the European market with evidence from a placebo-controlled RCT, but with several established competitors...